Sort   by:  
 Page size 
UnknownDNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
Not available
S-EPMC6214651 | biostudies-literature
UnknownA SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial.
Not available
S-EPMC2612543 | biostudies-literature
UnknownVirologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection.
Not available
S-EPMC12366723 | biostudies-literature
UnknownDNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial.
Not available
S-EPMC3620125 | biostudies-literature
UnknownTherapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire.
Not available
S-EPMC3654747 | biostudies-literature
UnknownHeterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.
Not available
S-EPMC10980745 | biostudies-literature
Sort   by:  
 Page size